Clinical Trial Update: Tiotropium and Salmeterol PK Study in COPD Patients [Phase 3]

View source ↗

Summary

A completed Phase 3 pharmacokinetics study in COPD patients evaluated the pharmacokinetics and potential interactions of tiotropium and salmeterol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Serevent (salmeterol)
• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED